Attached files

file filename
EX-10.14 - EX-10.14 - Cardiva Medical, Inc.d833938dex1014.htm
S-1 - S-1 - Cardiva Medical, Inc.d833938ds1.htm
EX-16.1 - EX-16.1 - Cardiva Medical, Inc.d833938dex161.htm
EX-10.27 - EX-10.27 - Cardiva Medical, Inc.d833938dex1027.htm
EX-10.26 - EX-10.26 - Cardiva Medical, Inc.d833938dex1026.htm
EX-10.25 - EX-10.25 - Cardiva Medical, Inc.d833938dex1025.htm
EX-10.24 - EX-10.24 - Cardiva Medical, Inc.d833938dex1024.htm
EX-10.23 - EX-10.23 - Cardiva Medical, Inc.d833938dex1023.htm
EX-10.22 - EX-10.22 - Cardiva Medical, Inc.d833938dex1022.htm
EX-10.21 - EX-10.21 - Cardiva Medical, Inc.d833938dex1021.htm
EX-10.20 - EX-10.20 - Cardiva Medical, Inc.d833938dex1020.htm
EX-10.19 - EX-10.19 - Cardiva Medical, Inc.d833938dex1019.htm
EX-10.18 - EX-10.18 - Cardiva Medical, Inc.d833938dex1018.htm
EX-10.17 - EX-10.17 - Cardiva Medical, Inc.d833938dex1017.htm
EX-10.16 - EX-10.16 - Cardiva Medical, Inc.d833938dex1016.htm
EX-10.15 - EX-10.15 - Cardiva Medical, Inc.d833938dex1015.htm
EX-10.13 - EX-10.13 - Cardiva Medical, Inc.d833938dex1013.htm
EX-10.12 - EX-10.12 - Cardiva Medical, Inc.d833938dex1012.htm
EX-10.11 - EX-10.11 - Cardiva Medical, Inc.d833938dex1011.htm
EX-10.5 - EX-10.5 - Cardiva Medical, Inc.d833938dex105.htm
EX-10.4 - EX-10.4 - Cardiva Medical, Inc.d833938dex104.htm
EX-10.3 - EX-10.3 - Cardiva Medical, Inc.d833938dex103.htm
EX-10.2 - EX-10.2 - Cardiva Medical, Inc.d833938dex102.htm
EX-10.1 - EX-10.1 - Cardiva Medical, Inc.d833938dex101.htm
EX-3.3 - EX-3.3 - Cardiva Medical, Inc.d833938dex33.htm
EX-3.1 - EX-3.1 - Cardiva Medical, Inc.d833938dex31.htm
EX-2.1 - EX-2.1 - Cardiva Medical, Inc.d833938dex21.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Cardiva Medical, Inc. of our report dated March 12, 2020 relating to the financial statements of Cardiva Medical, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ PricewaterhouseCoopers LLP
San Jose, California
January 4, 2021